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2',5'-Dideoxyadenosine 173




ACE inhibitors 246, 278, 333, 438
ACE inhibitors see also specific drugs
Acetates 244, 258
Acid-base equilibrium





Regulation 173, 174, 181, 216
Transport 456, 462
Acid-base imbalance .... 203, 215, 458, 465,
504
Acid-base imbalance see also specific
disorders
Acquired immunodeficiency syndrome see
AIDS
Active transport 187, 300, 463
Active transport see also Co-transport
Acute hypersensitivity nephritis ... 211, 228
Acute nephritis 346
Acute poststreptococcal




Drug effects on 316
Drug therapy 283, 401, 404, 416, 478





Pathophysiology.. 401, 408, 409, 411, 412,
414, 415, 422
Prevention & control.. 297, 407, 409, 415,
509, 526
Rehabilitation 233
Therapy 224, 252, 293
Acute tubular necrosis
Diagnosis 417
Pathophysiology 404, 408, 417, 419
Prevention & control 403, 416, 513
Acyl transferases 170
Adenosine
Analogs & derivatives 471
Antagonists & inhibitors 311, 416
Biosynthesis 431
Metabolism 183, 408
Pharmacologic actions 180, 258, 310,
315, 317, 436, 472, 473
Physiology 404, 475
Transport 401
Adenosine cyclic monophosphate see Cyclic
AMP
Adenosine triphosphate 399, 401, 443,
445, 450
Adenosine triphosphate see also ATPases
Adenylate cyclase... 174, 176, 299, 447, 477
Adenylate cyclase see also Cyclic AMP









Aging 162, 177, 347
AIDS




Mortality 209, 249, 261
Occurrence 259
Pathophysiology 485
AIDS see also Human immunodeficiency
virus









Albuminuria see also Microalbuminuria,
Proteinuria
Alcohol abuse 375




Physiology 455, 481, 486, 487
Pharmacologic actions 163, 300, 487
Regulation 460




Alport's syndrome 204, 206
549
Aluminum
Adverse effects .. 190, 193, 266, 268, 378,
379, 379, 380
Pathophysiology 381
Pharmacologic actions 253, 262, 400
Physiology 380
Toxicity 378, 398, 399
Transport 400
Aluminum hydroxide 222, 428
Amiloride
Analogs & derivatives 157, 466









Amino acids see also specific amino acids
Aminoglycosides 230, 407, 512
Aminoglycosides see also specific drugs
Aminonucleosides 210, 421
Ammonia




Ammonium chloride 174, 448









Drug therapy .... 194, 228, 230, 241, 246,
258, 266, 267, 274, 322, 335
Therapy 197
Anemia see also Erythrocytes,
Erythropoietin
ANF see Atrial natnuretic factor
Angiocardiography 415
Angiotensin converting enzyme... 235, 299,
483




Administration & dosage 299, 302
Antagonists & inhibitors... 208, 301, 303,
304, 417
550 Subject Index: Abstracts
Biosynthesis 326, 334
Metabolism 304, 305, 444
Pathophysiology 406, 475
Physiology 289, 303, 424, 44!, 459,
473, 474
Pharmacologic actions. 159, 173, 184, 197,
280, 301, 302, 303,
305, 321, 446, 461
Regulation 303, 304, 355
Secretion 339
Anions 165, 180, 494, 496
Ankylosing spondylitis 214
ANP see Atrial natriuretic factor
Antacids 262
Anti-inflam. agents, non-steroidal.. 207, 421
Antibiotics 248, 254, 512
Antibiotics see also specific drugs
Antibodies
Adverse effects 340, 350, 352






Antibodies see also Autoantibodies,
Monoclonal antibodies
Antibody formation 364, 515, 521
Antidiuretic hormone see Vasopressins,
SIADH
Antigen-antibody reactions 348, 361
Antigens
Adverse effects 345, 359, 366
Immunology 509
Isolation & purification 341
Physiology 345, 353
Regulation 510
Antigens see also Histocompatibility
antigens




Anuria see also Oliguria
Aorta 279
Arachidonic acids
Analogs & derivatives 313




Aromatic amino acid decarboxylases ... 313
Arteriolar nephrosclerosis 335
Arteriovenous shunt, surgical 260
Artificial membranes
Adverse effects 241, 243, 249, 257,
259, 267
Instrumentation 252, 261, 263
Methods 240, 262, 264





Atherosclerosis 202, 240, 334, 438
ATPases
Analysis 449, 463, 503
Antagonists & inhibitors ... 158, 321, 338,
432, 460, 467, 468
Drug effects on 300, 315
Isolation & purification 155
Pathophysiology 168, 419, 490
Pharmacokinetics 424
Pharmacologic actions 484
Physiology 158, 432, 453




Administration & dosage 284, 287
Analogs & derivatives 279, 282, 283,
284, 290
Analysis 208, 279, 280
Antagonists & inhibitors 288, 289
Blood 282, 284, 288, 290, 291, 406
Drug effects on 230
Isolation & purification 279, 290
Kinetics 280
Metabolism 286, 480
Physiology 278, 280, 282, 285, 287,
290, 409, 424
Pharmacologic actions 159, 280, 281,
281, 283, 284, 285,
285, 286, 286, 287,
288, 288, 289, 289,
301, 484
Regulation 472
Secretion .,.. 228, 265, 281, 283, 287, 442
Therapeutic use., 283, 412, 418, 421, 507,
510, 512
Atrial natriuretic factor binding
proteins 279
Autoantibodies
Adverse effects 342, 347
Biosynthesis 347, 364
Immunology 209, 227, 342
Isolation & purification 348
Pathophysiology 212, 370, 371
Autoantigens 373
Autoimmune injury 340, 342, 343, 344,
345, 346, 348, 349, 350,
355, 356, 357, 360, 361,
363, 365, 368
Autonomic nervous system
Growth & development 475
Pathophysiology 472, 520
Physiology 279, 329, 336, 355, 393
Autoregulation 469
AV fistula see Arteriovenous shunt
Azathioprine 507
Azotemia 191, 436
Azotemia see also Uremia
B cell lymphoma 511
B cells 348, 408, 527
Band 3 proteins 151, 153, 160,464










Beta adrenergic blockers 239








Drug effects on 453
Regulation 157, 445
Secretion 457, 458, 462, 463
Therapeutic use 242, 250, 264, 272
Transport ... 307, 385, 452, 453, 454, 455,
456, 457, 459, 460, 461, 461,
465, 466
Bile acids and salts 383
Binding sites
Analysis 317, 320




Biofilms 248, 272, 276
Bioimpedance 240




Ultrastructure 454, 457, 462
Bleeding time 236
Blood coagulation disorders.. 258, 295, 519,
526
Blood coagulation factors 199, 203, 511
Blood flow measurement 244
Blood gas analysis 215, 260
Blood groups 372, 523
Blood pressure 325, 327, 331, 338
Drug effects on... 241, 260, 284, 289, 302,
305, 310, 312, 314, 330, 335
Physiology 237, 265, 337
Blood proteins
Transport 276




Blood urea nitrogen 248, 256, 261
Body fluid compartments .,,. 238, 253, 265,
275, 495
Bombesin 319, 503





Pathophysiology 262, 379, 380
Prevention & control 378
Bone marrow 246
Subject Index: Abstracts 551
Transplantation 224, 420








Brain edema 218, 240
Bromides 220
Brush border
Analysis 154, 160, 389
Anatomy & histology 160, 165
Drugeffectson 412
Physiology 151, 165, 167, 169, 383




C3 nephritic factor 373
Cadaveric transplantation
Complications 527






Pharmacologic actions . 312, 316, 322, 392
Physiology 392
Therapeutic use 526
Calcitonin gene related peptide 312
Calcitriol
Biosynthesis 393
Metabolism 391, 396, 397
Physiology 392
Therapeutic use 392
Calcitriol see also Vitamin D
Calcium
Adverse effects 405
Analogs & derivatives 222, 293
Intracellular. 157, 169, 172, 172, 176, 178,
181, 183, 280, 294, 302, 310,
315, 325, 332, 333, 338, 388,
394, 399, 439, 464, 506
Metabolism 255, 339, 427
Pathophysiology 410
Pharmacologic actions 167, 293, 475
Physiology 395, 436




Transport ... 170, 178, 180, 184, 184, 185,
280, 381, 382, 383, 385, 387, 388,
398, 494
Urine 195
Calcium carbonate 256, 265
Calcium channel blockers 282, 283, 292
Calcium channel blockers see also specific
agents
Calcium channels see also Ion channels
Calcium citrate 400
Calcium ketovalin 389













CAPD see also Peritoneal dialysis
Captopril
Diagnostic use 303, 332, 336
Pharmacologic actions. 212, 288, 327, 328,
335
Therapeutic use 198, 200, 337, 423
Carbicarb 464
Carbohydrates 249, 499
Carbon dioxide 454, 455, 467
Carbonic acid 462
Carbonic anhydrase 454, 457, 462, 466
Carbonic anhydrase inhibitors 430
Cardiac output 332, 464
Cardiac pacing, artificial 284
Carnitine 267, 268
Carrier proteins
Analogs & derivatives 165




Catecholamines 215, 258, 268, 483
Drug effects on 333









Cell adhesion 157, 187, 353, 362
Cell communication 174, 474, 509
Cell culture techniques 168, 420
Cell death 409
Cell differentiation 171, 175, 187, 315
Cell division 452







Ultrastructure 161, 163, 189
Cell membrane permeability .. 188, 189, 362
Cell proliferation ... 174, 177, 180, 180, 185,
185, 307, 340, 358, 385,
402, 409
Antagonists & inhibitors... 158, 188, 278,
508
Drug effects on 448
Pathophysiology 179, 341
Physiology 429
Regulation .. 180, 184, 319, 321, 346, 349,




Regulation .. 156, 161, 185, 479, 480, 484,
488, 489, 490, 492, 501, 504
Cells, cultured 161, 344, 349, 356, 361,
362, 508




Chemotactic factors 255, 343, 362, 370
Chemotaxis 362
Chloride channels see Ion channels
Chlorides
Deficiency 453, 456, 465, 467
Intracellular 486
Physiology 455
Regulation .. 157, 168, 479, 482, 482, 486,
487
Transport ... 161, 177, 307, 433, 454, 455,
456, 457, 458, 477, 481, 485, 488,
489, 492, 503
Cholesterol 151, 240, 438, 474
Cholesterol embolism 229
Chondroitin 353
Chromatography.... 169, 184, 358, 511, 515




Complications.... 193, 200, 236, 239, 253,
272, 397, 423, 436
Diagnosis 234, 440
Diet therapy 227, 425
Drug therapy .... 221,221,230,319,380,
385, 428, 441
Etiology 224, 229, 230
Immunology 199, 372, 376
Metabolism 196, 391, 396, 447
Mortality 524
Occurrence 223, 235
Outcome 191, 195, 199
Pathophysiology.. 198, 222, 277, 285, 286,
295, 347, 393, 395
Therapy 224







Cisplatin 219, 384, 403, 410
Citrate synthase 486
552 Subject Index: Abstracts
Citrates 338, 379, 399, 444
Clindamycin 245





Physiology 452, 499, 503
Regulation .. 155, 169, 179, 179, 304, 325,
455, 458, 463






Biosynthesis 323, 349, 350, 361, 430,
437






Physiology 166, 432, 449, 498
Transport.... 451, 452, 483, 485, 490, 502
Ultrastructure.... 151, 401, 420, 454, 465,
466, 504
Colon neoplasms 248
Colony stimulating factors.... 343, 356, 368
Complement
Adverse effects 354, 356, 364





Physiology 243, 249, 257, 267, 269,
342, 363
Secretion 241
Complement activation... 259, 309, 366, 373
Computers 227, 260, 468
Concanavalins 165, 355, 361
Concentrating ability 494
Confocal microscopy 187, 189
Congestive heart failure.. 231, 259, 284, 288
Connecting tubules 394
Continuous ambulatory pentoneal dialysis
see CAPD
Contrast media 232, 413





Creatinine 201, 232, 527
Creatinine clearance 198, 223
Cross infection 243, 254
Crystal growth inhibitor 364
Cuprophan see under Artificial membranes
Cyanate 197
Cyclic AMP
Antagonists & inhibitors 177
Biosynthesis 319
Intracellular 156, 294, 296
Metabolism 163, 179
Pharmacologic actions 173, 181






Pharmacologic actions 170, 484
Physiology 286
Urine 285
Cyclophosphamide 208, 211, 212, 347
Cyclosporine nephropathy 408
Cyclosporins
Administration & dosage 214
Adverse effects .. 182, 332, 337, 408, 505,
507, 509, 511, 512, 520,
526
Analogs & derivatives 506
Drug therapy 343
Pharmacokinetics . 511, 514, 515, 517, 518
Pharmacologic actions 403, 477, 508
Physiology 509
Therapeutic use... 349, 367, 513, 519, 521
Toxicity 198, 358, 402, 405, 406, 410,
414, 448, 505, 506, 508, 509, 510,
517, 520, 522, 525
Cystic renal disorders
Diagnosis 192
Pathophysiology 168, 304,31!, 312,
358, 360, 365, 435








Cytoskeletal proteins .... 167, 188, 189, 357
Cytoskeleton 189







Dexamethasone 161, 406, 482
Diabetes mellitus... 295, 298, 426, 427, 441,
497
Complications.... 191, 218, 221, 227, 236,
314, 438, 451
Diet therapy 424, 426
Drug therapy 423, 430
Pathology 160, 164
Pathophysiology 171, 299, 434, 436,
468, 472, 473
Prevention & control 336
Therapy 215, 336
Diabetic glomerular injury 211, 212
Diabetic nephropathy
Complications 227
Drug effects on 470
Drug therapy 337
Pathophysiology.. 194, 20!, 273, 293, 305,
314, 433, 439, 441, 44!
Diacylglycerol 170, 176, 467
Dialysate.. 248, 250, 252, 256, 256, 265, 268





Dialysis see also Hemodialysis, Peritoneal
dialysis, CAPD
Dialysis machines 238, 245, 251, 261
Dialysis machines see also Artificial
membranes, Catheters
Dialyzing membranes see under Artificial
membranes
2',S'-Dideoxyadenosine 173
Diet., 196, 198, 218, 222, 236, 257, 282, 314,
338, 349, 365, 386, 453, 481
Dietary fats 257, 424





Pharmacologic actions 311, 471
Physiology 190, 193, 302, 303, 494






Disease models, animal 355
Distal tubules .. 167, 459, 462, 480, 493, 501
Distal tubules see also Pars convoluta, Pars
rectal
Distension 167, 464
Diuresis 286, 433, 482
Diuretics 162, 332
Diuretics see also specific agents









Antagonists & inhibitors.... 173, 286, 478
Pharmacologic actions 154, 322, 329
Physiology 309
Regulation 321
Therapeutic use 231, 421
Urine 317
Dose-response relationships 281
Doxorubicin 402, 421, 434, 473
Drug abuse see Substance abuse
Drug administration routes... 242, 270, 273,
277, 280, 287
Drug metabolism 447, 449, 515
Drug transport 159







Pathophysiology 402, 407, 410, 416,
417, 420, 421, 438
Prevention & control 405, 406, 409
Echocardiography 241
EDRF see Endothelium derived relaxing
factors
EGF see Epidermal growth factor
Eicosapentaenoic acid 236




Administration & dosage 302
Adverse effects 435, 526
Analogs & derivatives 339
Diagnostic use 328, 330
Pharmacologic actions. 201, 208, 282, 305,
327





Occurrence 192, 198, 200, 201, 227
Outcome 201
Therapy 195, 200
End-stage renal disease see also Chronic
renal failure
Endocytosis 188, 189, 189, 321, 444
Endopeptidases 314
Endorphins 329
Endosomes 153, 455, 503
Endothelial cells









Pharmacologic actions. 172, 178, 185, 309,





factors 307, 326, 331




Epidemiologic methods 201, 213, 335




Pharmacologic actions . 313, 315, 320, 421





Anatomy & histology 151
Antibodies to 360
Classification 158
Growth & development 429
Injuries 340, 404, 434, 505, 526
Metabolism 153
Pathophysiology 446
Physiology .. 155, 157, 170, 180, 316, 358,
454, 500
Transport 310








Physiology 209, 430, 433
Urine 375
Erythropoiesis 246, 253, 319, 322
Erythropoietin
Adverse effects .. 191, 199, 238, 241, 254,
257, 265, 266, 314
Biosynthesis 289
Pharmacokinetics 274
Pharmacologic actions 264, 319
Secretion 327
Therapeutic use.. 191, 194, 196, 197, 228,
230, 237, 238, 241, 244,
246, 247, 248, 251, 253,
254, 258, 260, 267, 317,
322, 335, 430, 438





Biosynthesis 295, 344, 351, 433




Extracellular space 260, 468
Eye 353
Fabry's disease 203
Familial Mediterranean fever 213






Fibroblasts 179, 180, 187, 309
Fibronectins 157, 160, 163, 345, 352
Fish 290
Fish oil 294, 329, 369, 413, 415, 424
Fistula see Arteriovenous shunt
Fluconazole 273
Fluid replacement 215, 217
Fluid-electrolyte disorders 213, 235
Fluid-electrolyte disorders see also specific
disorders
Fluorescence 155, 381, 486, 492
Fluorescence microscopy 4%
Fluorescent probes.. 171, 461, 485, 486, 492
Focal/segmental sclerosis
Diet therapy 349




Pathophysiology.. 340, 345, 351, 424, 425,
426, 429, 430, 431, 434,
435, 437, 440, 443
Therapy 524
Follow-up studies 517, 522, 524
Foot processes 357
Formic acid 462
Free radicals .. 272, 320, 404, 408, 413, 415,
422
Furosemide 305, 381, 433, 453, 482
G proteins 155, 177, 179, 182, 185, 298,
303, 397, 497




Gene expression regulation.... 156, 170, 177,
186, 301, 303, 304,
334, 343, 512
Genes 179, 184, 357, 416
Genetic linkage 204, 206, 207
Genetics, biochemical 153, 365, 497
Gentamicin
Adverse effects 407, 504
Toxicity 402, 406, 407, 412, 416, 419
GFR see Glomerular filtration rate
Glomerular filtration rate
Drug effects on... 279, 287, 310, 313, 323,
357, 436, 471, 475, 475,
476, 476
Growth & development 489
Methods 202, 211
Pathophysiology.. 214, 226, 233, 234, 327,
337, 365, 425





Immunology 360, 372, 374, 376, 377
Occurrence 192
Pathophysiology.. 342, 344, 345, 355, 361,
365, 368, 439, 440, 442
Prevention & control 355
Therapy 345
Glomerulonephritis see also specific
disorders
Glomerulus
Anatomy & histology 151, 423, 437
554 Subject Index: Abstracts
Drug effects on 309
Growth & development 165, 451
Injuries 341, 425, 425, 428
Metabolism 297, 473
Pathology ... 347, 351, 353, 356, 373, 377,
426
Pattiophysiology 425
Physiology .. 160, 279, 298, 317, 320, 438,
468, 469, 470, 474
Secretion 160, 352, 362
Transport 350
Ultrastructure 371








Glucocorticoids see also specific agents
Glucose
Antagonists & inhibitors 438
Biochemical actions 323
Drug effects on 446
Metabolism 153, 185, 245
Physiology 398, 439
Transport 152, 182, 448, 451, 503








Antagonists & inhibitors 386















Prevention & control.. 505, 508, 513, 513,
521, 523,
Graft vs host disease 354, 355
Growth hormone 195, 270, 316, 386
Growth releasing hormone 386
Growth substances 2%, 311
Guanine nucleotide binding proteins see G
proteins
Guanine triphosphate . . . . 3%
Guanosine cyclic monophosphate see Cyclic
GMP
Guanylate cyclase 289
Guanylate cyclase see also Cyclic GMP
Haplotypes 206
Health maint. organizations 200
Health services administration 246
Heart 244, 283, 516
Heart diseases 423, 522, 524
Heart surgery 250, 526
Heart, artificial 279, 290
Hematocrit 242, 244, 251, 265, 272
Hematuria 210, 221, 223
Heme oxygenase 447, 449
Hemodialysis
Adverse effects .. 194, 215, 241, 243, 245,
247, 252, 254, 259
Complications.... 193, 239, 240, 243, 244,
245, 247, 248, 253, 254, 255,
258, 259, 262, 264, 265, 268,
268, 322, 347
Immunology 256, 257, 372
Metabolism 267
Methods .... 238, 239, 240, 242, 243, 244,
247, 249, 250, 251, 252, 255, 257,
257, 258, 260, 260, 261, 262, 263,
263, 264, 264, 266, 268
Mortality 246, 255, 257, 261
Outcome 252
Pharmacologic actions 246, 253
Physiology .. 237, 240, 241, 244, 249, 252,
253, 256, 258, 265, 265, 267
Rehabilitation 384
Standards 244, 256, 263
Therapeutic use 250, 518
Utilization 238
Hemodynamics












Hemolytic-uremic syndrome . 224, 231, 232,
233
Hemostasis 236, 519
Henoch-Schonlein purpura 369, 373
Heparan sulfate 164, 166, 188
Heparin 258, 340
Adverse effects 360
Analogs & derivatives 439, 447
Isolation & purification 160
Pharmacologic actions 288
Therapeutic use 240, 243
Hepatitis B vaccine 371


















HIV infection see AIDS or Human
immunodeficiency virus
HLA system see Histocompatibility antigens
Home hemodialysis 266
Human immunodeficiency virus... 256, 259,
269





Antagonists & inhibitors 468
Intracellular 168
Physiology 301, 308
Regulation 489, 491, 493
Secretion 459, 460, 466, 467
Transport ... 157, 159, 174, 175, 187, 187,
218, 307, 324, 331, 452, 452, 453,




Hydronephrosis 208, 229, 477
Hydrostatic pressure 275, 489
6-Hydroxydopamine 402
Hyperaldosteronism 332, 472














Prevention & control 250
Hyperlipidemia. 247, 423, 426, 427, 437, 520
Hypernatremia 215, 497, 499
Hyperoxaluria 205




Complications.... 206, 221, 236, 327, 339,
524
Diet therapy 324, 329, 331, 338
Drug effects on 199
Drug therapy. 200, 201, 329, 335, 338, 339
Subject Index: Abstracts 555
Etiology .... 191, 195, 225, 258, 314, 323,
325, 326, 337, 339
Familial & genetic 282
Metabolism 292
Occurrence 205, 207, 234
Pathophysiology.. 202, 317, 324, 328, 329,
330, 333, 337, 339, 365,
397, 423, 429, 472, 511
Prevention & control 336
Surgery 233
Therapy 194
Hypertension see also Renovascular
hypertension
2K1C Hypertension 287, 303
Hypocalcemia 216, 219, 382
Hypochloremia 220










Hypoxia 404, 410, 413, 483
latrogenic disease 225





Immunology 350, 357, 371, 374
Occurrence 192
Pathology 210, 371
Pathophysiology 199, 348, 354, 372,
373, 373
Immune complexes
Adverse effects 352, 357, 364
Analysis 210





Physiology 342, 363, 367
Urine 360
Immunity, cellular .. 175, 363, 364, 367, 510
Immunoglobulins
Adverse effects 358, 362, 366
Analysis 203








Therapeutic use 518, 521
Transport 270, 432
Urine 151
Immunohistologic techniques 370, 375
Immunologic cytotoxicity 355
Immunologic factors 309
Immunologic techniques 187, 370, 394
Immunosuppression 199, 211, 354, 506,
511, 513, 516
Immunosuppressive agents 231, 520
Immunosuppressive agents see also specific
agents
Immunotherapy 513, 518, 522
Indomethacin 441
Infection 231, 243, 245, 250, 264
Infection see also Pyelonephritis
Inflammation 357
Inner stripe 459








Inositol triphosphate .... 169, 173, 175, 176,
180, 182, 184, 186
Insulin
Antagonists & inhibitors 152
Metabolism 444
Pathophysiology 327
Pharmacologic actions 327, 448, 476
Physiology 398, 414
Secretion 215, 428
Insulin-like growth factors ... 152, 172, 180,
377
Antagonists & inhibitors 437
Biosynthesis 309
Drug effects on 311
Pharmacologic actions 186, 313,
Physiology 182, 316
Integrin 160
Intercalated cells 463, 467
Classification 151, 454




Intercellular junctions 152, 164
Interferons 176
Interleukins ... 196, 264, 356, 361, 367, 371,
374, 376, 527
Adverse effects 357











Intestinal absorption 219, 382, 389, 436
Intracellular fluid 412
Intracellular pH.... 168, 173, 336, 388, 451,




Regulation 324, 330, 446, 451, 452,
454, 457, 457, 458, 461, 461,
463, 464, 465, 467
Intracellular signal
transduction. 171, 171, 172, 172, 173, 175,
176, 176, 178, 178, 179, 179,
181, 181, 182, 183, 183, 184,





Analysis 171, 178, 492
Antagonists & inhibitors 156
Antibodies to 161
Isolation & purification 161, 479
Pathology 480, 488
Physiology 156, 163, 170, 477
Regulation .. 154, 155, 166, 167, 168, 177,
181, 280, 481, 484, 488
Transport 468, 492
Ion exchange
Antagonists & inhibitors 157, 460
Drug effects on 304
Pathology 457
Physiology .. 160, 165, 172, 182, 272, 307,
412, 452, 458, 467, 494
Regulation 167, 179, 307, 496
Ion exchange see also Co-transport
Iron 242, 247, 254, 267
Ischemia 294, 401, 403, 405, 411, 413,







Anatomy & histology 431, 433, 435
Growth & development.... 224, 353, 381,
393, 428, 435, 441,
475
Metabolism 300, 446, 449












Leukocytes 274, 369, 373, 377
556 Subject index: Abstracts
Leukocytes see also Neutrophils,
Lymphocytes
Leukotrienes
Analogs & derivatives 293
Antagonists & inhibitors 292, 507
Biosynthesis 296, 340
Immunology 178
Pharmacologic actions 289, 299
Secretion 292
Light chain deposits 374
Light chain disease 210
Lipases 191, 351, 361
Lipid peroxides 494, 518
Lipids










Lithium 306, 318, 323, 480
Lithium clearance 208
Lithotripsy 326




Pathophysiology 285, 285, 308, 476
Prevention & control 242
Liver neoplasms 442
Loop of Henle
Drug effects on 469, 477
Injuries 410
Physiology 167, 311, 312,449, 474





Drug therapy 222, 236





Drug effects on 359




Pathophysiology .. 190, 214, 342, 352, 367
Therapy 231
LY146032 221





Macrophages 296, 344, 351, 361, 368,
427, 508
Macula densa 300, 501
Magnesium 378, 381, 384
Magnetic resonance imaging .. 331, 433, 493
Magnetic resonance spcctroscopy.. 323, 386










Melanocyte stimulating hormone 328
Melphalan 210
Membrane fluidity.. 151, 155, 156, 162, 164,
329
Membrane potentials 152, 478
Membrane proteins. 154, 158, 165, 167, 188,
374
Membranes 160, 164, 277, 310
Membranes see Artificial membranes, Cell
memhranes
Membranous glomerulonephritis




Pathophysiology 341, 354, 364
Mercury 411, 418, 498
Mesangial cells
Analysis 183
Drug effects on 309, 510
Growth & development..., 170, 180, 184,




Injuries 346, 356, 434
Isolation & purification 362
Metabolism 182, 186, 186, 403, 430
Pathophysiology 175, 341, 343, 368
Physiology .. 154, 174, 178, 278, 293, 308,
320, 321, 433, 440, 506
Regulation ... 163, 315, 319, 321, 344, 349
Secretion.... 181, 309, 310, 343, 345, 349,
350, 351, 358, 361
Transport 159, 439
Ultrastructure 157, 432
Mesanginl matrix protein 346
Mesangial proliferative









Pathophysiology.. 218, 383, 390, 391, 453,
455, 460, 461, 463, 467
Therapy 215
Metabolic alkalosis . 217, 455, 456, 457, 465,
467
Metals 411
Microalbuminuria 226, 236, 441
Microalbuminuria see also Albuminuria,
Proteinuria
Microbiologic techniques 235, 273, 276
Microcirculation
Anatomy & histology 516
Analysis 280
Antibodies to 373
Drug effects on... 273, 283, 290, 292, 302,










Drug therapy 198, 202, 237
Pathophysiology 209, 222
Minimal change disease see also Nephrotic
syndrome
Misoprostol 521
Mitochondria... 403, 404, 405, 406, 418, 422
Monoclonal antibodies... 154, 362, 370, 508




Multiple myeloma 200, 374
Muscles 268, 414, 434, 439
Mutagenesis 387
Myasthenia gravis 220
















Nephrocalcinosis 213, 223, 381
Nephrogenic diabetes insipidus ... 203, 207,
495
Nephrons 313, 360, 365, 456, 463, 469







Subject Index: Abstracts 557
Diet therapy 473
Drug therapy 202, 212, 214, 237, 433
Familial & genetic 206
Immunology 374
Pathology 376
Pathophysiology 287, 402, 430, 437
Therapy 237
Nephrotic syndrome see also Minimal
change disease
Nervous system diseases 253
Nervous system physiology 328
Neurofibromatosis 205




Antibodies to 227, 347
Immunology 249
Metabolism 249, 267, 272
Pathophysiology 516
Physiology 362
Nicardipine 318, 329, 405
Nickel 420
Nickel nephropathy 420
Nifedipine 405, 428, 441, 513, 514
Nitrendipine 338
Nitrogen 192, 399
Nitroprusside 225, 280, 327
Non-amyloidotic fibrillary
glomerulopathy 234




Nutrition 226, 227, 239, 275
Obesity 225, 230
Ocular hypertension 240
OKT3 immunotherapy 513, 514, 515
Oliguria 225, 232, 233, 419
Oliguria see also Anuria
Omeprazole 463, 467, 468
Oncogenes 365
Oncotic pressure 499
Organ preservation 506, 510
Organ procurement 234, 525
Ornithine decarboxylase 402
Osmolarity 159, 189, 488, 495, 500
Osmolytes 153, 493, 497, 499, 500












Oxalate nephropathy 205, 435
Oxalates 256, 276, 499
Oxidoreductases 297, 305, 422
Oxygen 347
Oxygen consumption 218, 446, 449
Oxytocin 504
P-glycoprotein 159
PAF see Platelet activating factor
Pancreatic diseases 191, 234
Parathyroid glands 390, 393, 396, 396,
398
Parathyroid hormones
Antagonists & inhibitors 255
Blood 394
Drug effects on 391
Metabolism 244
Pharmacologic actions. 173, 179, 181, 181,
185, 189, 194, 282,
388, 392, 393, 436
Physiology 301, 390, 392, 394, 395,
397, 398




Parenteral nutrition 223, 239
Pars convoluta . 185, 388, 460, 463, 482, 490
Pars recta 161, 388
Particle arrays 503
PDGF see Platelet-derived growth factor
Pedigrees 204
Pepsinogens 504
Peptides 317, 361, 504
Percutaneous angioplasty 193
Peritoneal dialysis 271, 273, 274, 435
Analysis 273
Complications 276




Physiology 275, 275, 277
Utilization 271









Drug therapy 273, 275
Etiology 276
Immunology 274, 343
Occurrence 268, 269, 269
Prevention & control 276
Permeability 247, 276, 277, 278
Drug effects on 498
Regulation 188, 462, 500
Permselectivity 333











Transport.... 151, 382, 384, 385, 389, 395
Phosphate see also Phosphorus
Phosphate metabolism disorders... 256, 265
Phosphatidyl inositol synthase 156
Phosphodiesterases 307, 495
Phospholipases 182, 298, 299
Antagonists & inhibitors 177, 303
Isolation & purification 293
Physiology 183
Regulation 169




Diet therapy 385, 391
Metabolism 339, 428, 439
Pathophysiology 456
Regulation 388, 396
Transport ... 166, 172, 383, 386, 387, 387,
392








Plasminogen activators 181, 182, 186
Platelet activating factor
Antagonists & inhibitors 409
Biosynthesis 311
Pathophysiology 321, 442
Pharmacologic actions 176, 294
Physiology 183, 186, 420
Platelet aggregation 511
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Deficiency 216, 456, 461, 491
Diet therapy 325, 331
Pharmacologic actions 297
Physiology 388
Regulation .. 162, 163, 460, 483, 487, 489,
490, 492
Secretion 483, 484, 487, 492
Standards 485
Transport ... 162, 162, 181, 217, 326, 467,





Administration & dosage ... 202, 209, 214




Pregnancy complications 205, 226, 339
Prenatal diagnosis 207
Principle cells 454, 467
Prognosis 199, 249, 259, 261, 524
Prolactin 264
Proliferative ON see Mesangial proliferative
ON
Propionates 496
Prostaglandin synthase 297, 313, 321
Prostaglandins
Analogs & derivatives 416
Antagonists & inhibitors.... 287, 298, 447
Biosynthesis. 158, 291, 292, 293, 294, 295,
2%, 297, 298, 319, 355, 403,
410, 431, 494, 506, 509
Metabolism 177, 180, 365
Pharmacologic actions. 169, 295, 471, 495,
497
Physiology 299, 481
Secretion 278, 292, 295, 298, 483
Urine 293, 294, 297
Protamine 152, 277
Proteases 409
Protein see also Dietary proteins
Protein C 227
Protein catabolism 448, 450
Protein electrophoresis 334
Protein kinases
Antagonists & inhibitors.... 308, 394, 498
Pathophysiology 325
Pharmacologic actions 173, 465
Physiology .. 155, 164, 175, 177, 179, 306,
395, 479, 484







Diagnosis 220, 226, 231
Drug effects on 321
Drug therapy 198, 212, 228
Etiology 352, 365
Occurrence 225, 234
Pathophysiology 222, 314, 323, 333,
354, 365, 421, 426, 434,
473





Biosynthesis . 161, 165, 295, 342, 345, 353
Immunology 342
Isolation & purification 353
Proximal tubules 390
Drug effects on 382
Growth & development 168, 315
Injuries 362, 408, 410, 411, 414, 414,
417, 419, 421, 505, 516, 526
Metabolism.. 165, 174, 387, 391, 394, 445,
447
Pathophysiology 367, 424
Physiology .. 152, 153, 156, 161, 301, 318,
324, 469, 470, 490, 493, 501,
502
Secretion 323
Transport 319, 403, 427, 451, 452,
453, 455, 458, 461, 477, 483, 484,
486, 488, 496, 496
Ultrastructure 401, 411, 412, 458





Puromycin aminonucleoside see under
Aminonucleosides
Pyelonephritis 195, 224, 235, 372
Quality of health care 263
Quality of life 1%, 197, 247, 248
Questionnaires 197
Radiography 328, 415
Radioimmunoassay 511, 515, 517
Radionuclide imaging 335, 419





glomerulonephritis.... 211, 227, 348, 375,
375
Rapidly progressive glomerulonephritis,
Type I 209, 346, 356, 363, 367, 442
Rapidly progressive glomerulonephritis,
Type II 321, 348, 351,365
Reabsorption 386, 504
Drug effects on 414




Receptors, adenosine 315, 416
Receptors, alpha adrenergic.. 164, 312, 318,
489
Receptors, ANF see Receptors, peptide
Receptors, angiotensin 434, 441
Receptors, beta adrenergic 163, 312
Receptors, diuretic 478, 491








Physiology 342, 356, 368
Receptors, insulin 152, 434
Receptors, leukotriene 292
Receptors, lipoprotein 440
Receptors, peptide . 186, 208, 279, 280, 282,
283, 286, 289, 305, 308,
326
Receptors, prostaglandin 299
Receptors, steroid 170, 183
Receptors, thromboxane 298, 506
Related donor transplantation 513, 516,
519, 520, 521,
525
Renal adaptation ... 157, 177, 291, 296, 300,
305, 311, 320, 385, 425, 435,
436, 440, 451, 501
Renal arteries 307, 429, 471, 512
Renal artery disease 193
Renal artery stenosis 225, 327, 334
Renal blood flow
Drug effects 199
Drug effects on 305, 322, 323, 328,
333, 417, 469, 476
Growth & development 474
Methods 229
Pathophysiology.. 234, 333, 337, 415, 468,
472
Physiology 193, 318, 471, 471
Regulation 314, 318, 324, 405, 470
Renal cortex 422, 443, 474




Renal interstitial pressure 288
Renal medulla 282, 312, 422, 456
Renal medulla see also Inner zone, Outer
zone
Renal nerves 197, 405
Renal osteodystrophy 378, 379, 380




Pathophysiology 214, 360, 388
Physiology 155, 414, 439
Transport 445
Renal tubules see also Distal tubules,
Proximal, Collecting tubules
Renin
Analogs & derivatives 302
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Drug effects on 332
Physiology 424
Regulation 207, 303, 318






Diagnosis 324, 330, 332, 336
Drug effects on 328
Drug therapy 513
Etiology 331, 334, 335, 335, 474
Occurrence 332, 334






Rheumatoid factor 203, 366
Rifampin 272, 275
Risk factors.... 199, 243, 246, 247, 248, 270
RNA 156, 407
RNA see also Messenger RNA
Salicylates 422














Signal transduction see Intracellular signal
transduction
Skin 239
Sleep apnea syndrome 225
Snake venoms 341
Sodium
Administration & dosage 228, 304
Adverse effects 219
Antagonists & inhibitors 466
Blood 290
Deficiency 301, 453
Diet therapy. 324, 325, 326, 328, 329, 338,
431
Metabolism 327, 330
Pharmacologic actions 152, 314
Physiology 323, 337
Regulation .. 168, 304, 328, 329, 338, 387,
457, 476, 480, 482, 483, 484,
486, 487, 489, 489, 493
Secretion 485, 489
Transport ... 152, 157, 159, 172, 175, 182,
187, 187, 190, 283, 289, 300, 303,
313, 315, 318, 319, 323, 324, 326,
329, 330, 331, 333, 387, 389, 395,
430, 443, 452, 452, 454, 455, 456,
456, 458, 459, 461, 465, 465, 469,
472, 478, 479, 480, 481, 483, 484,
490,491, 494
Urine... 190, 280, 281, 287, 299, 301, 424,
442, 478
Sodium channels see also Ion channels
Soluble immune response suppressor... 374
Solute removal 241, 247, 252, 275
Somatomedins 313, 316
Somatomedins see also Insulin-like growth
factors
Somatostatin 460
















Sulthydryl groups 166, 385
Sulfonamides 211
Sulindac 292
Superficial nephrons 454, 474
Superoxide dismutase 400, 403
Surgical wound infection 512
Sympathetic nervous system see under
Autonomic nervous system
Sympathomimetics 239, 446, 477
T cells
Biosynthesis 506
Drug effects on 509





TGF see Transforming growth factors
Theophylline 404






Analogs & derivatives . 292, 295, 296, 403
Antagonists & inhibitors... 208, 298, 417,
509, 511




Thyroid hormones 168, 169, 235
Tobramycin 245, 417
Tomography, computed 192, 271, 330
Toxic/metabolic nephropathies.... 358, 411,
418, 509
Transcription, genetic... 171, 184, 416, 432,
442
Transforming growth factors.. 187, 342, 433
Transplant rejection see Graft rejection
Transplantation
Adverse effects 515
Complications .... 514, 517, 520, 523, 526
Drugtherapy 512,512,518,525
Immunology 507, 515, 527
Metabolism 527






Utilization... 514, 515, 517, 520, 522, 522,
524
Transplantation see also Cadaveric
transplantation, Related donor
transplantation







Tubular secretion 223, 339
Tubules see Distal tubules, Proximal,
Collecting tubules
Tubuloglomerular feedback .. 454, 468, 469,
470, 474
Tubulointerstitial diseases.... 346, 350, 369,
419
Tubulointerstitial diseases see also specific
disorders










Ultrasound imaging 192, 271, 527
United States 201





Growth & development 386
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Metabolism 392, 393, 397, 428, 499
Pathophysiology 202
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Uric acid disorders 209
Uric acid nephropathy 220
Urinalysis 192, 226, 237, 370




Pathophysiology 228, 288, 300, 432
Therapy 229
Urodynamics 233





Drug effects on 281, 285, 290, 298,
303, 322, 329, 332, 337,
429, 473, 475, 505, 513
Etiology 512
Pathophysiology 415
Physiology 307, 326, 33!
Regulation 258, 297, 308, 315, 318,
320, 325, 336, 473
Vascular smooth muscle
Drug effects on 332
Pathophysiology 325, 334, 336
Pharmacologic actions 163, 327
Physiology 184, 307, 330, 332
Transport 331
Vascular surgery 229, 233
Vasculitis 209, 227
Vasoactive intestinal peptide 216
Vasoconstriction 413
Vasopressins
Administration & dosage ,,. 236, 306, 308
Analogs & derivatives 287
Antagonists & inhibitors.... 203, 207, 306
Drug effects on 294
Pharmacologic actions. 153, 159, 170, 172,
173, 182, 189, 302,
308, 312, 445, 446,
48!, 490, 494, 496,
498, 500, 502, 504







Verapamil 364, 367, 404, 428, 441, 475
Visual evoked potentials 190
Vitamin A 430
Vitamin C 245, 262, 276, 277, 435, 436
Vitamin D
Administration & dosage 3%
Adverse effects 351
Analogs & derivatives. 176, 255, 283, 339,
394, 394, 398







Therapeutic use 221, 391, 401
Vitamin D see also Calcitriol
Vitamin E 415, 435, 436
Volume expansion.. 281, 282, 319, 473, 480,
489




Transport ... 188, 294, 306, 313, 491, 493,
496, 498, 499, 500, 501, 502, 503
Water channels. 153, 158, 189, 306, 498, 503
Water expansion 281
Water immersion 284, 288
Water-electrolyte balance.... 216, 240, 262,
284, 290, 290, 483
Wegener's granulomatosis 371
Xanthine oxidase 413
Z-riboside 449
Zinc 400
